World's Best Scientists 2026 revealed!
Pediatric Blood and Cancer
H-index 36

Pediatric Blood and Cancer

Ranking & Metrics

Discipline name Position Best Scientists Publications D-Index
Medicine 507 377 798 34

Additional Metrics

Number of Best Scientists*: 667
Documents by Best Scientists*: 1084
Top 100 Ranked Scientists*: 14
SCIMAGO H-index: 133
SCIMAGO SJR: 0.994
Impact Factor: 2.3

Overview

Top Research Topics at Pediatric Blood & Cancer?

The topics of Internal medicine, Pediatrics, Surgery, Oncology and Chemotherapy are the focal point of discussions in Pediatric Blood & Cancer. In addition to Internal medicine research, the journal aims to explore topics under Gastroenterology and Immunology. Topics in Pediatrics explored in Pediatric Blood & Cancer were investigated in conjunction with research in Incidence (epidemiology), MEDLINE, Young adult, Blood cancer and Cohort.

In the Surgery research discussed, Survival rate and Transplantation are all tackled. The main emphasis of the journal is the research on Transplantation, emphasizing the topic of Hematopoietic stem cell transplantation. While work presented in the journal provided substantial information on Oncology, it also covered topics in Neuroblastoma and Pathology.

It investigates Chemotherapy research which frequently intersects with Radiation therapy. It emphasizes research on Cancer, which includes concerns such as Pediatric cancer.

  • Internal medicine (32.54%)
  • Pediatrics (19.40%)
  • Surgery (16.35%)

What are the most cited papers published in the journal?

  • HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. (2855 citations)
  • Highly elevated ferritin levels and the diagnosis of hemophagocytic lymphohistiocytosis (389 citations)
  • The pediatric preclinical testing program: description of models and early testing results. (378 citations)

Research areas of the most cited articles at Pediatric Blood & Cancer:

The journal papers are organized to reinforce research efforts on Internal medicine, Surgery, Pediatrics, Oncology and Chemotherapy. While work presented in the most cited articles provide substantial information on Internal medicine, it also covers topics in Gastroenterology and Sarcoma, Pathology. The journal papers address concerns in Pediatrics which are intertwined with other disciplines, such as Cancer, Incidence (epidemiology), MEDLINE, Young adult and Disease.

What topics the last edition of the journal is best known for?

  • Internal medicine
  • Cancer
  • Disease

The previous edition focused in particular on these issues:

Pediatric Blood & Cancer generally zeroes in on subjects such as Internal medicine, Oncology, Coronavirus disease 2019 (COVID-19), Cancer and Family medicine. The studies tackled, which mainly focus on Internal medicine, apply to Gastroenterology as well. Coronavirus disease 2019 (COVID-19) research featured in the journal incorporates concerns from various other topics such as MEDLINE and 2019-20 coronavirus outbreak.

Cancer research is concerned with Childhood cancer in particular. The studies in Family medicine featured incorporate elements of Pediatric cancer, Health care and Pediatric oncology. Topics in Cohort were tackled in line with various other fields like Retrospective cohort study and Pediatrics.

The most cited articles from the last journal are:

  • COVID-19 and children with cancer: Parents' experiences, anxieties and support needs (19 citations)
  • Characterization of COVID-19 disease in pediatric oncology patients: The New York-New Jersey regional experience. (18 citations)
  • COVID-19 in pediatric cancer patients in a resource-limited setting: National data from Peru. (13 citations)

Papers citation over time

A key indicator for each journal is its effectiveness in reaching other researchers with the papers published at that venue.

The chart below presents the interquartile range (first quartile 25%, median 50% and third quartile 75%) of the number of citations of articles over time.

The top authors publishing in Pediatric Blood & Cancer (based on the number of publications) are:

  • Richard Gorlick (90 papers) published 3 papers at the last edition the same number as at the previous edition,
  • John M. Maris (88 papers) absent at the last edition,
  • Peter J. Houghton (88 papers) published 3 papers at the last edition, 2 more than at the previous edition,
  • Malcolm A. Smith (84 papers) published 2 papers at the last edition, 2 less than at the previous edition,
  • Andrea Ferrari (82 papers) published 3 papers at the last edition, 6 less than at the previous edition.

The overall trend for top authors publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top authors.

Only papers with recognized affiliations are considered

The top affiliations publishing in Pediatric Blood & Cancer (based on the number of publications) are:

  • Boston Children's Hospital (1725 papers) published 157 papers at the last edition, 14 more than at the previous edition,
  • St. Jude Children's Research Hospital (626 papers) published 59 papers at the last edition, 8 more than at the previous edition,
  • Harvard University (386 papers) published 43 papers at the last edition, 8 more than at the previous edition,
  • University of Toronto (323 papers) published 31 papers at the last edition, 5 more than at the previous edition,
  • Baylor College of Medicine (323 papers) published 39 papers at the last edition, 6 more than at the previous edition.

The overall trend for top affiliations publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top affiliations.

Publication chance based on affiliation

The publication chance index shows the ratio of articles published by the best research institutions in the journal edition to all articles published within that journal. The best research institutions were selected based on the largest number of articles published during all editions of the journal.

The chart below presents the percentage ratio of articles from top institutions (based on their ranking of total papers).Top affiliations were grouped by their rank into the following tiers: top 1-10, top 11-20, top 21-50, and top 51+. Only articles with a recognized affiliation are considered.

During the most recent 2021 edition, 9.09% of publications had an unrecognized affiliation. Out of the publications with recognized affiliations, 46.36% were posted by at least one author from the top 10 institutions publishing in the journal. Another 5.91% included authors affiliated with research institutions from the top 11-20 affiliations. Institutions from the 21-50 range included 10.61% of all publications and 37.12% were from other institutions.

Returning Authors Index

A very common phenomenon observed among researchers publishing scientific articles is the intentional selection of journals they have already attended in the past. In particular, it is worth analyzing the case when the authors participate in the same journal from year to year.

The Returning Authors Index presented below illustrates the ratio of authors who participated in both a given as well as the previous edition of the journal in relation to all participants in a given year.

Returning Institution Index

The graph below shows the Returning Institution Index, illustrating the ratio of institutions that participated in both a given and the previous edition of the conference in relation to all affiliations present in a given year.

The experience to innovation index

Our experience to innovation index was created to show a cross-section of the experience level of authors publishing in a journal. The index includes the authors publishing at the last edition of a journal, grouped by total number of publications throughout their academic career (P) and the total number of citations of these publications ever received (C).

The group intervals were selected empirically to best show the diversity of the authors' experiences, their labels were selected as a convenience, not as judgment. The authors were divided into the following groups:

  • Novice - P < 5 or C < 25 (the number of publications less than 5 or the number of citations less than 25),
  • Competent - P < 10 or C < 100 (the number of publications less than 10 or the number of citations less than 100),
  • Experienced - P < 25 or C < 625 (the number of publications less than 25 or the number of citations less than 625),
  • Master - P < 50 or C < 2500 (the number of publications less than 50 or the number of citations less than 2500),
  • Star - P ≥ 50 and C ≥ 2500 (both the number of publications greater than 50 and the number of citations greater than 2500).

The chart below illustrates experience levels of first authors in cases of publications with multiple authors.

Career Path and Required Skills in Pediatric Oncology Research

It's worth noting the vital role healthcare professionals, particularly those with a specialization in pediatric oncology, play in conducting groundbreaking research in pediatric cancers. These practitioners often become involved in research alongside their clinical duties, contributing significantly to the advancements in the field. Potential contributors to the Pediatric Blood & Cancer journal may be steered to this path through a variety of routes. For example, registered nurses may opt to advance their training through participating in relevant nurse practitioner programs. Those who have an interest in focusing on children's health can choose a pediatric nurse practitioner program. Specifically, investigating required educational and licensing steps can provide a clear path, for instance, you can review the **nurse practitioner program requirements in Iowa** for insights. Once qualified, the next step is to gain experience and specialize in pediatric oncology. This field indulges those with a profound sense of empathy, strong communication skills, and a robust understanding of childhood cancer. As specialists, these individuals can efficiently contribute their clinical insights to research and academic writing, therein orienting the course of study towards practical, impactful outcomes. It is also important to keep up with the latest research, not only for personal learning and development but also to contribute more effectively to the field. By merging clinical expertise and academic research, pediatric oncology practitioners can help extend the boundaries of our knowledge about pediatric cancers. For those considering this path or currently on it, the profession carries potential for immense professional achievement and personal fulfillment. The fusion of healthcare and research fosters an environment of constant learning, growth, and the potential to make significant contributions to improving children's health.

Top Publications

  • The COVID-19 pandemic: A rapid global response for children with cancer from SIOP, COG, SIOP-E, SIOP-PODC, IPSO, PROS, CCI, and St Jude Global.

    Michael Sullivan;Eric Bouffet;Carlos Rodriguez-Galindo;Sandra Luna-Fineman

    (2020)
    154 Citations
  • Early advice on managing children with cancer during the COVID-19 pandemic and a call for sharing experiences.

    Eric Bouffet;Julia Challinor;Michael Sullivan;Andrea Biondi

    (2020)
    135 Citations
  • An update on rhabdomyosarcoma risk stratification and the rationale for current and future Children's Oncology Group clinical trials

    (2022)
    108 Citations
  • Children with cancer in the time of COVID-19: An 8-week report from the six pediatric onco-hematology centers in Lombardia, Italy.

    Andrea Ferrari;Marco Zecca;Carmelo Rizzari;Fulvio Porta

    (2020)
    108 Citations
  • Characterization of COVID-19 disease in pediatric oncology patients: The New York-New Jersey regional experience.

    P. Pallavi Madhusoodhan;Joanna Pierro;Jordan Musante;Prachi Kothari

    (2021)
    100 Citations
  • How young patients with cancer perceive the COVID-19 (coronavirus) epidemic in Milan, Italy: Is there room for other fears?

    Michela Casanova;Elena Pagani Bagliacca;Matteo Silva;Carlo Patriarca

    (2020)
    99 Citations
  • Delayed cancer diagnoses and high mortality in children during the COVID-19 pandemic.

    Yang‐Yang Ding;Sneha Ramakrishna;Adrienne H. Long;Charles A. Phillips

    (2020)
    72 Citations
  • No increase in psychosocial stress of Dutch children with cancer and their caregivers during the first months of the COVID‐19 pandemic

    (2020)
    67 Citations
  • Phase 1/2 trial of talazoparib in combination with temozolomide in children and adolescents with refractory/recurrent solid tumors including Ewing sarcoma: A Children's Oncology Group Phase 1 Consortium study (ADVL1411).

    Eric S. Schafer;Rachel E. Rau;Stacey L. Berg;Xiaowei Liu

    (2020)
    62 Citations
  • Sarcopenia is a prognostic outcome marker in children with high-risk hepatoblastoma.

    Annika Ritz;Julian Kolorz;Jochen Hubertus;Julia Ley-Zaporozhan

    (2021)
    60 Citations

Related Online Degrees & Career Pathways

For students interested in expanding their medical knowledge beyond traditional medicine, several related online degrees offer flexible learning options. For example, those aiming to enter the pharmaceutical field can explore pharm d online programs, which provide comprehensive training in drug therapy and patient care while accommodating busy schedules.

In addition, careers focused on physical health and rehabilitation are growing rapidly. Accredited programs like an exercise science degree online accredited or online kinesiology programs emphasize human movement, fitness, and wellness, making them ideal for those seeking to work in physical therapy, sports medicine, or wellness coaching.

Mental health is another critical area with an increasing demand for skilled professionals. Prospective psychiatric nurses can pursue the fastest pmhnp program to quickly gain credentials in psychiatric-mental health nursing, enabling them to provide specialized care in various healthcare settings.

Each of these pathways complements a traditional medical education by broadening career opportunities and supporting a holistic approach to healthcare delivery.

Best Scientists Contributing to This Journal